New to Meducation?
Sign up
Already signed up? Log In
view moderators

MultipleSclerosis

Category

Preview
0
7

MS drug 'may already be out there' - BBC News

Depression and heart-disease drugs are to be tested in a trial to find treatments for Multiple Sclerosis (MS) from existing medicines.  
bbc.co.uk
over 5 years ago
Preview
0
6

MS drug 'may already be out there' - BBC News

Depression and heart disease drugs are to be tested in a new trial to find treatments for Multiple Sclerosis (MS).  
bbc.co.uk
over 5 years ago
Preview
0
13

HIV and multiple sclerosis: beginning to unravel a mystery

Stream HIV and multiple sclerosis: beginning to unravel a mystery by BMJ talk medicine from desktop or your mobile device  
feeds.bmj.com
over 5 years ago
Preview
0
19

Diagnosing and treating neuromyelitis optica

Stream Diagnosing and treating neuromyelitis optica by BMJ talk medicine from desktop or your mobile device  
feeds.bmj.com
over 5 years ago
Preview
0
10

Dimethyl fumarate (BG-12) first line oral treatment for people with multiple sclerosis | Cochrane

Dimethyl fumarate was approved by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency for adults with relapsing-remitting multiple sclerosis (RRMS). It does not require that any other medication be tried before dimethyl fumarate is prescribed. Although data from non Cochrane reviews are available, it is important to systematically evaluate its efficacy and safety as monotherapy versus placebo.  
cochrane.org
over 5 years ago
Preview
0
12

Telerehabilitation for persons with multiple sclerosis | Cochrane

Does telerehabilitation achieve better outcomes in persons with multiple sclerosis compared with traditional face-to-face intervention? What types of telerehabilitation interventions are effective, in which setting and influence which specific outcomes?  
cochrane.org
over 5 years ago
Preview
0
1

The management of spasticity in adults

Spasticity is a frequent and debilitating feature of common neurological conditions such as stroke, multiple sclerosis, and traumatic brain and spinal cord injuries  
feeds.bmj.com
about 5 years ago
Preview
0
6

The struggle of being a parent with multiple sclerosis - BBC News

Nicola Smith, who has multiple sclerosis, tells the Victoria Derbyshire programme she is worried that her condition will lead her son to miss out.  
bbc.co.uk
about 5 years ago
Preview
1
15

Radiology: Multiple Sclerosis: Improved Identification of Disease-relevant Changes in Gray and White Matter by Using Susceptibility-based MR Imaging

To evaluate the potential of quantitative susceptibility (QS) and R2* mapping as surrogate biomarkers of clinically relevant, age-adjusted demyelination and iron deposition in multiple sclerosis (MS).  
pubs.rsna.org
almost 5 years ago
Preview
0
6

Low vitamin-D genes linked to MS - BBC News

People genetically prone to low vitamin-D levels are at increased risk of multiple sclerosis, a large study suggests.  
bbc.co.uk
almost 5 years ago
Preview
5
171

Cerebrospinal fluid

The cerebrospinal fluid (CSF) is produced from arterial blood by the choroid plexuses of the lateral and fourth ventricles by a combined process of diffusion, pinocytosis and active transfer. A small amount is also produced by ependymal cells. The choroid plexus consists of tufts of capillaries with thin fenestrated endothelial cells. These are covered by modified ependymal cells with bulbous microvilli. The total volume of CSF in the adult ranges from140 to 270 ml. The volume of the ventricles is about 25 ml. CSF is produced at a rate of 0.2 - 0.7 ml per minute or 600-700 ml per day. The circulation of CSF is aided by the pulsations of the choroid plexus and by the motion of the cilia of ependymal cells. CSF is absorbed across the arachnoid villi into the venous circulation and a significant amount probably also drains into lymphatic vessels around the cranial cavity and spinal canal. The arachnoid villi act as one-way valves between the subarachnoid space and the dural sinuses. The rate of absorption correlates with the CSF pressure. CSF acts as a cushion that protects the brain from shocks and supports the venous sinuses (primarily the superior sagittal sinus, opening when CSF pressure exceeds venous pressure). It also plays an important role in the homeostasis and metabolism of the central nervous system.  
neuropathology-web.org
almost 5 years ago
Preview
0
0

Exercise therapy for fatigue in multiple sclerosis | Cochrane

Multiple sclerosis (MS) is a chronic disease affecting over 1.3 million people globally. MS is characterized by diffuse damage to the central nervous system, leading to a wide range of different physical and cognitive (mental processes) symptoms. One of the most prominent and disabling symptoms of MS is fatigue. Currently, there is no effective medicine to reduce fatigue in people with MS. Treatment with exercise may be a way to reduce fatigue either directly by changing how the body works, for example hormonal function, or indirectly through improved physical activity and general health.  
cochrane.org
almost 5 years ago
Preview
0
0

Smoking May Speed Up MS Disease Course

Continued smoking after a diagnosis of multiple sclerosis may be associated with accelerated disease progression, a new study suggests.  
medscape.com
almost 5 years ago
Preview
0
0

Prognostic Factors for Developing Multiple Sclerosis

What are the characteristics that might predict multiple sclerosis development and disability accumulation?  
medscape.com
almost 5 years ago
Preview
0
0

Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis | Cochrane

Different therapeutic strategies are available for the treatment of people with relapsing-remitting multiple sclerosis (RRMS), including immunomodulators, immunosuppressants, and biologics. Although there is consensus that these therapies may reduce the frequency of relapses, their relative benefit (effectiveness compared to each other) in delaying new relapses or disability worsening remains unclear due to the limited number of direct comparison studies (i.e. studies comparing two or more active agents with each other).  
cochrane.org
almost 5 years ago
Preview
0
0

Effective Patient Communication for Multiple Sclerosis Treatment Success CME/CE

This activity is intended for clinicians including neurologists, primary care physicians, obstetricians and gynecologists who care for patients with MS.  
medscape.org
almost 5 years ago
Preview
0
0

Cannabinoids and the Progression of Multiple Sclerosis

This study aimed to determine if THC might slow the progressive phase of MS by way of its neuroprotective properties.  
medscape.com
almost 5 years ago
Preview
0
0

Managing Relapse -- When to Switch Disease-Modifying Therapy? CME

This activity is intended for neurologists, primary care providers, and other clinicians involved in the management of patients with multiple sclerosis.  
medscape.org
almost 5 years ago
Preview
0
1

Shared Decision Making Across the Spectrum of Multiple Sclerosis Management CME/CE

This activity is intended for neurologists, primary care physicians, psychiatrists, and nurses who care for patients with multiple sclerosis (MS).  
medscape.org
almost 5 years ago